Select committee: Science and Technology Committee

Ageing: Science, Technology and Healthy Living

Closed Opened 25 Jul 2019 Closed 20 Oct 2021 23 recommendations 39 conclusions
Inquiry scope (the committee's words)
While life span has increased over recent decades, health span, the period of time people live in good health, has generally not kept pace, and so older people are living longer with ill health. This inquiry will investigate how approaches from science and technology could be used to increase health span, to mitigate some of the negative effects of ageing, and to support older people living with poor health.

Where it stands

The inquiry is closed, opened 25 July 2019.

The committee has published 1 report, most recently 1st Report - Ageing: Science, Technology and Healthy Living on 15 January 2021.

The government's response

Published 15 March 2021. The deadline was 15 March 2021.

Summary written by Accountability Index from the government's response. It is not the government's own words.

The government says it is determined to tackle health inequalities and is already acting, states that some recommendations are already implemented, does not support making Comprehensive Geriatric Assessment a core part of medical training, and will review the 2017 Grand Challenges and missions.

  • On a designated clinician for older patients, the government says the recommendation "has already been implemented", citing the requirement that patients aged 75 and over be assigned an accountable GP.
  • It states "We do not support" making the Comprehensive Geriatric Assessment a core part of medical training, saying it "would not be appropriate" for all specialties as the assessment is not relevant to them.
  • On health inequalities, it says it will come forward with proposals in response to the Prevention Green Paper "in due course", which will form elements of plans to reduce inequalities over the next Parliament.
  • On the Ageing Society Grand Challenge, it says it will review the 2017 Grand Challenges and missions as part of work on a new Innovation Strategy, to be developed "in the coming months".

Read the government's response ↗ Report an error

Recommendations and conclusions 62 shown

Conclusion 1

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Life expectancy in the UK continues to rise, but since 2011 it has risen at a slower rate. Healthy life expectancy is not keeping pace with increases in life expectancy, resulting in a growing period of poor health towards the end of life. Inequalities in healthy life expectancy are stark, with people in the least deprived groups living more than 18 years longer in good health than those in the most deprived groups.

Link to this item · Read this item

Recommendation 2

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Government, along with NHS England, Public Health England, and other agencies, prioritise reducing health inequalities. In its response to this report we request that the Government sets out a plan for reducing health inequalities over the next Parliament.

Link to this item · Read this item

Conclusion 3

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Multimorbidity—the state of having two or more long-term conditions—is more common in old age. There is evidence that the rate of multimorbidity is increasing, so it will become an increasing issue for the NHS. The environmental and biological factors driving the development of multimorbidity are not fully understood.

Link to this item · Read this item

Conclusion 4

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Care pathways are not well coordinated or integrated for older people, particularly those with multimorbidity. Patients often have to see multiple doctors, with multiple specialisms, with little coordination between specialists to reduce the burden on patients.

Link to this item · Read this item

Recommendation 5

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that, as was proposed in 2013, the NHS ensures that all older patients have a designated clinician. This clinician would have oversight of the patient’ s care as a whole, and should coordinate activity across multidisciplinary teams, which should include members from across the health and social care sectors. The clinician could be from either primary or secondary care, depending on the patient’s needs.

Link to this item · Read this item

Recommendation 6

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that designated clinicians for older people ensure that Comprehensive Geriatric Assessments are used regularly for older patients, particularly for those with multimorbidity. The Government should ensure that training in how to conduct Comprehensive Geriatric Assessments is a core part of medical training, and that training is provided on an ongoing basis, in particular to GPs.

Link to this item · Read this item

Conclusion 7

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Medicine reviews are a core component of Comprehensive Geriatric Assessments, and if these are used more widely, with the involvement of multidisciplinary teams, the incidence of polypharmacy and the risk of adverse drug reactions should reduce.

Link to this item · Read this item

Recommendation 8

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the review into overprescribing—which is due to report to the Secretary of State for Health and Social Care in late 2020—should be published as soon as possible.

Link to this item · Read this item

Conclusion 9

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Understanding of the underlying biological processes of ageing has advanced significantly in animal models, but translation to human ageing is incomplete. The lack of accurate biomarkers for human ageing is an impediment to assessing an individual’s biological age.

Link to this item · Read this item

Conclusion 10

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Promising advances have been made in the development of drugs that target the underlying processes of ageing. These could delay the onset of age-related diseases and reduce polypharmacy. Research into repurposing drugs is particularly welcome, as such drugs have already been tested for safety, dosage and tolerability.

Link to this item · Read this item

Conclusion 11

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The fact that clinical trials are usually approved only if they target a single indication poses a challenge to research into drugs that target underlying ageing processes. The novel design of the TAME trial in the US hopes to provide proof of concept for trials targeting the ageing process itself.

Link to this item · Read this item

Recommendation 12

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Medicines and Healthcare products Regulatory Agency (MHRA) show greater willingness to approve trials which target multiple conditions. It should also explore the use of novel trial endpoints, such as using biomarkers of ageing as measures of success in treatments targeting the ageing process.

Link to this item · Read this item

Conclusion 13

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Historically, clinical trials excluded older people and people with multimorbidity, and some continue to do so. This is a particular issue for drugs targeting the ageing process, as older people and those with multimorbidity will be the main recipients of such drugs.

Link to this item · Read this item

Recommendation 14

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Medicines and Healthcare products Regulatory Agency (MHRA) ensures that older people are included more frequently in clinical trials, particularly where the drug will be used primarily in that population. When developing novel trial designs for drugs targeting the ageing process, as recommended above, these should also allow for inclusion of people with multimorbidity.

Link to this item · Read this item

Conclusion 15

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
How to target ‘anti-ageing’ drugs to provide the greatest benefit to the individual, the NHS and society will be an important issue in future but requires further research and evidence from clinical trials. A health economics analysis of such treatments will be needed to determine the optimal time and populations for intervention.

Link to this item · Read this item

Conclusion 16

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
There has been a lack of effort since our report in 2005 to ensure research into ageing—as opposed to research into specific age-related disease—is properly funded, co-ordinated and included within the remit of particular research councils. This may have contributed to the poor translation of basic research into clinical trials or new medicines.

Link to this item · Read this item

Recommendation 17

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that UK Research and Innovation commit to funding further research into the biological processes underlying ageing as a priority, in particular to address gaps in understanding the relevance of ageing hallmarks to humans. Research to identify accurate biomarkers of ageing in humans should also be prioritised, to support studies to improve health span.

Link to this item · Read this item

Recommendation 18

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that UK Research and Innovation and the National Institute for Health Research support further research into drugs that target the ageing process—including proof of concept trials using repurposed drugs (such as in the TAME trial).

Link to this item · Read this item

Recommendation 19

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that UK Research and Innovation and the National Institute for Health Research commit to working more closely to ensure rapid translation of ageing research into clinical benefit.

Link to this item · Read this item

Recommendation 20

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Chief Medical Officer is given responsibility for overseeing the coordination of ageing research between UK Research and innovation and the National Institute for Health Research.

Link to this item · Read this item

Conclusion 21

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The UK has historically been a major player in drug research and development, and has the potential to be a key player in the development of treatments targeting the processes of ageing. However, companies in the UK struggle to commercialise such innovations and often have to move abroad to access finance.

Link to this item · Read this item

Recommendation 22

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Government ensure the UK remains a global leader in drug research and development. It should work towards making the UK a more attractive environment for growth capital investment, to stop UK innovations moving abroad after the discovery stage of research.

Link to this item · Read this item

Conclusion 23

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
There was scepticism from the research community that the target of five extra years of healthy life can be achieved by 2035, and a view that the focus of the Industry Strategy Challenge fund on technological solutions and data analysis is unlikely to help deliver the target.

Link to this item · Read this item

Conclusion 24

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The UK has the opportunity to be a leader in understanding the impacts of lifestyle on health, using its well-established cohort studies in conjunction with its expertise in emerging areas of biomedical research. To achieve this, it is important that longitudinal cohort studies are provided with longer-term funding that gives greater security to these studies. It is also important that cohort studies recruit sufficient numbers of people from different ethnicities and socioeconomic groups to better understand health inequalities in older adults and how these may be resolved in the longer term.

Link to this item · Read this item

Conclusion 25

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The impacts of smoking and excessive alcohol consumption upon ageing—and the potential for ill health and disability in old age—may be an important issue for some people when considering their behaviours and so could be an effective part of public health messaging.

Link to this item · Read this item

Conclusion 26

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Eating a balanced diet and maintaining a healthy body weight into old age are key to healthy ageing. Dietary advice has to reflect the nutritional needs of older people and the diversity of those needs.

Link to this item · Read this item

Conclusion 27

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The benefits of physical activity are a cornerstone of public health advice, but a more detailed understanding of its positive effects—and the negative effects of sedentary time—could allow the development of advice that is more targeted. This is important throughout the life-course, including for older adults who have lower levels of physical activity.

Link to this item · Read this item

Conclusion 28

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Cognitive ability and psychological stresses are key aspects of health throughout the life-course, but they also influence general health and might affect the underlying processes of ageing. Cognitive activities—including education, training and good-quality employment—and reduced stress are means of improving health in later life.

Link to this item · Read this item

Conclusion 29

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The factors that contribute to healthy life expectancy are well known, and form the basis of healthy ageing advice, namely: not smoking, avoiding excessive alcohol consumption, eating a balanced and nutritious diet, maintaining a healthy body weight, and being physically active. There is also evidence of the role of cognitive activity and reduced stress in healthy ageing.

Link to this item · Read this item

Conclusion 30

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Despite the evidence linking behaviours throughout the life-course to health in old age, the potential gains from healthy behaviours are not being fully achieved. Different aspects of the evidence could potentially have an impact upon people’s behaviours, for example: the fact that healthy lifestyles can reduce the time spent with disability in old age; and the discovery that behaviours can modify underlying processes of ageing.

Link to this item · Read this item

Recommendation 31

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that organisations with responsibility for healthy ageing advice incorporate findings about the benefits of healthy behaviours that may have a larger impact upon people’s behaviour than existing messaging. The benefits of building up good levels of physical fitness and cognitive reserve should be promoted, particularly to people in disadvantaged groups that suffer the worst health.

Link to this item · Read this item

Conclusion 32

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
There is a need to better understand the scientific basis of the mechanisms by which lifestyle factors affect ageing. There is also a need to understand how requirements change in old age in order to develop advice covering, for example: the nutritional needs of older people; the benefits of physical activity for cognitive health; and the impacts of sedentary time.

Link to this item · Read this item

Recommendation 33

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that UK Research and Innovation and the National Institute for Health Research ensure that they support interventional studies to establish the mechanisms by which lifestyle and environmental factors affect health in old age, in order to improve advice for healthy ageing.

Link to this item · Read this item

Conclusion 34

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Public Health England’s advocacy for a life-course approach to healthy ageing is to be commended. Early uptake and adherence to a healthy lifestyle may continue into mid- and later life, but it is never too late to benefit from an improved lifestyle. Interventions tend to be more successful if they are designed with an understanding of what motivates people at different ages and the transition points at which they are more likely to act on public health advice.

Link to this item · Read this item

Conclusion 35

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
A balanced approach to public health advice can help to achieve healthy ageing, with general messages provided to the whole population and tailored advice for groups with specific needs—in particular, disadvantaged groups who suffer from the worst health.

Link to this item · Read this item

Recommendation 36

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Government clearly defines the roles and responsibilities for healthy ageing among national and local government and their agencies. The creation of the National Institute for Health Protection should be used as an opportunity to revitalise work to promote healthy ageing across the life-course, including by improving coordination across the sector and drawing on the best information for developing public health advice.

Link to this item · Read this item

Recommendation 37

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Government implement a concerted and coordinated set of national policies to support healthy ageing, including: regulatory and fiscal measures, actively to encourage people to adopt lifestyles that support healthy ageing ; increasing the reach of the NHS Health Check to those in disadvantaged groups who will benefit the most; and working with local authorities on the funding of local services, housing and infrastructure to encourage and facilitate healthier living across the life-course, including the necessary services to maintain health and independence in old age.

Link to this item · Read this item

Recommendation 38

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Government use planning rules to ensure that homes and communities are accessible for people with limited mobility and adaptable as their needs change with age. The Government should ensure that sufficient funds are available—for example through the Disabled Facilities Grant—to facilitate improvements to existing homes. The priority should be areas with poor housing and infrastructure, in order to reduce health inequalities.

Link to this item · Read this item

Conclusion 39

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
More widespread use of telecare services—particularly modern digital systems with monitoring capabilities—may enable more people to live independently in their homes for longer in old age. The upcoming digital telephone switchover provides impetus for this change and is an opportunity for local authorities to introduce more comprehensive services to facilitate safe and independent living.

Link to this item · Read this item

Conclusion 40

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Data-driven services and emerging robotics and AI systems could provide significant support to older people, to enable them to live independently for longer. The results of ongoing projects in the UK and abroad will help to determine what role robotics can play.

Link to this item · Read this item

Recommendation 41

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Government makes targeted and strategic investments in research for the design, evaluation and uptake of data-driven services, assistive robot technologies and AI for older people, in order to develop national expertise and critical mass in this important area.

Link to this item · Read this item

Conclusion 42

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The use of wearable and implantable technologies for monitoring health conditions and administering treatments is likely to become increasingly common. Such technologies have potential to provide more precise and timely treatment, and could contribute to better health and greater independence in old age.

Link to this item · Read this item

Conclusion 43

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Non-medical devices can be a source of useful information for individuals seeking to live more healthily. It will be necessary for the Government to continue to monitor developments in the sector to ensure an appropriate approach to standards.

Link to this item · Read this item

Conclusion 44

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The Government is to be commended for developing its loneliness strategy. Older people need strong social contacts, with the priority being face-to-face interactions. There is also the need for people to develop digital skills to use technologies that can reduce social isolation and loneliness.

Link to this item · Read this item

Conclusion 45

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
With much healthcare data now held electronically, alongside data generated by non-medical devices, there is a valuable opportunity to develop more sophisticated methods of monitoring and predicting how well people age. There is a need to further reduce technical barriers to data integration across different platforms and administrative barriers to providing anonymised patient data for clinical trials.

Link to this item · Read this item

Conclusion 46

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
In order to improve uptake and usefulness of technologies and services that can contribute to healthier and independent living in old age, it is important to base the process of development and deployment around older people’s needs, preferences and abilities. It is beneficial for older people to be involved in the design of these products and services.

Link to this item · Read this item

Conclusion 47

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Public trust in data security is key if data-driven services and new technologies are to be deployed widely and used to their potential. Ongoing public engagement will be necessary to reassure the public on matters of trust and privacy regarding healthcare data, so that people are more willing to share data that can contribute to their own healthcare and to the development of wider advice for healthy ageing.

Link to this item · Read this item

Recommendation 48

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that Government ensures internet access for all homes so that older people can access services to help them live independently and in better health. The Government should promote and support lifelong digital skills training so that people enter old age with the ability to use beneficial technologies. Greater support should be provided to the large proportion of the current older generation which lacks these skills, so that they do not miss out on the benefits of available technologies.

Link to this item · Read this item

Conclusion 49

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The funding for new innovation in products and services seems to be aimed more at larger companies, presumably in the hope of achieving commercialisation more quickly and with less risk. However, small and medium-sized enterprises contribute significantly to innovation, and there would be merit in these organisations having easier access to funding to support innovation.

Link to this item · Read this item

Conclusion 50

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
There is significant potential for development of new technologies and services to support healthier and independent living in old age, including medical devices and robotics. There is scope for further deployment of existing technologies such as telecare and ‘activities of daily living’ systems.

Link to this item · Read this item

Conclusion 51

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
Technology and services can contribute to independence and social connectedness in old age, and to health to a lesser extent, but it seems unlikely that they can add five years of healthy and independent living by 2035. Moreover, there is a risk of technology and services widening health inequalities in old age, due to barriers to uptake that are more prevalent in disadvantaged groups. The Government will have to intervene decisively and for the long-term in order to make these tools ubiquitous and beneficial for the whole population in old age.

Link to this item · Read this item

Recommendation 52

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
When allocating funding through the Ageing Society Grand Challenge, we recommend that the Government supports the deployment of technologies that contribute to healthier and independent living—both those available now and those that may become available in future . This should prioritise disadvantaged groups in order to bring the greatest health benefits, whilst also realising economic benefits of innovations that are developed in the UK .

Link to this item · Read this item

Conclusion 53

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The Government is not on track to achieve the Ageing Society Grand Challenge mission to ensure five years of extra healthy life by 2035 while reducing inequalities, and does not appear to be monitoring progress towards the mission. It is hard to see how the target could be met without significant changes to the way it is managed.

Link to this item · Read this item

Recommendation 54

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Government review the feasibility of the target to increase healthy life expectancy by five years by 2035, and revise or re-commit to it. The Secretary of State for Health and Social Care should commit to reporting annually to Parliament on progress towards the target. The Government should also revise or re-commit to the target to reduce inequalities and outline measurable targets for the reduction in inequalities it hopes to achieve by 2035.

Link to this item · Read this item

Conclusion 55

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
It is not clear who in Government is responsible for overseeing the Ageing Society Grand Challenge mission, aside from broad ministerial oversight from the Secretary of State for Health and Social Care. We are concerned that this policy has no clear ownership.

Link to this item · Read this item

Conclusion 56

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The position taken by the Government that the challenge and the mission are overlapping but distinct is confusing, and we are concerned that achieving the mission does not appear to be at the core of the Grand Challenge.

Link to this item · Read this item

Recommendation 57

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Secretary of State for Health and Social Care appoints a senior responsible officer for achieving the mission of the Ageing Society Grand Challenge, as this does not appear to be covered by the senior responsible officer for the challenge.

Link to this item · Read this item

Conclusion 58

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
We are concerned that there is not a cross-government strategy for achieving the mission. Without one, the Ageing Society Grand Challenge is unlikely to achieve the mission of increasing healthy life expectancy by five years while reducing inequalities.

Link to this item · Read this item

Conclusion 59

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The Government’s statement that the part of the mission pertaining to inequalities is not the sole responsibility of the Ageing Society Grand Challenge is confusing. Other aspects of policy will contribute to this goal, but that does not mean that reducing inequalities should not be at the core of the cross-government strategy for healthy ageing.

Link to this item · Read this item

Recommendation 60

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the Secretary of State for Health and Social Care—along with the senior responsible officer—produces a cross-government strategy which clearly states how the Government plans to achieve the Ageing Society Grand Challenge mission by 2035 . The strategy should include a roadmap for how the Government intends to achieve the mission, and should specify the departments responsible for working towards the target.

Link to this item · Read this item

Recommendation 61

Recommendation · 1st Report - Ageing: Science, Technology and Healthy Living

Recommended (the committee's words)
We recommend that the cross-government strategy explicitly addresses the issue of reducing inequalities in healthy ageing, without ‘passing the buck’ to wider Government goals or statutory obligations. In producing the strategy, the Government should seek wide input from stakeholders; most importantly, from older people.

Link to this item · Read this item

Conclusion 62

Conclusion · 1st Report - Ageing: Science, Technology and Healthy Living

Concluded (the committee's words)
The COVID-19 pandemic has shown tragically how poor health makes people more vulnerable to further health risks, and has highlighted the health inequalities associated with deprivation—including for ethnic minorities. The pandemic has harmed the health of the wider population, and the longer-term health impacts—including on mental health—are unknown, increasing the need for action to encourage and facilitate healthy ageing.

Link to this item · Read this item

Reports

1 report

Oral evidence sessions

11 sessions

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

Date Session and witnesses Source
11 Mar 2020
Oral evidence session
Professor Sir Michael Marmot · University College London (UCL)
View ↗
10 Mar 2020
Oral evidence session
Dr Alison Cave · UK Research and Innovation, Dr Fiona Marshall · Academy of Medical Sciences, Dr Lauren Walker · British Pharmacological Society, Dr Louise Wood CBE · Department of Health and Social Care, Dr Sheuli Porkess · Association of the British Pharmaceutical Industry, Jim Mellon · Juvenescence, Professor Fiona Watt · Medical Research Council, Tamsin Berry · Office for Life Sciences
View ↗
3 Mar 2020
Oral evidence session
Ami Shpiro · Innovation Warehouse, Dr Anna Dixon · Centre for Ageing Better, George MacGinnis · UK Research and Innovation, Luella Trickett · Association of British HealthTech Industries, Professor Judith Phillips OBE · UK Research and Innovation, Professor Mariana Mazzucato · University College London (UCL), Rosamond Roughton · Department for Health and Social Care
View ↗
25 Feb 2020
Oral evidence session
Charles Lowe · Digital Health and Care Alliance, Chris Roebuck · NHS Digital, Dame Fiona Caldicott · Health and Adult Social Care Data in England, Dr Jem Rashbass · NHS Digital, Dr Jeni Tennison · Open Data Institute, Dr Paola Zaninotto · University College London, Matthew Gould CMG MBE · NHSX, Professor Julian Peto · London School of Hygiene and Tropical Medicine
View ↗
11 Feb 2020
Oral evidence session
Catherine McClen · BuddyHub, Dr Chris Blackmore · University of Sheffield, Dr Sana Suri · University of Oxford, Mr Simon Ommundsen · No Isolation, Professor Barbara Sahakian · University of Cambridge, Professor Jane Raymond · University of Birmingham, Professor Russell Foster · University of Oxford, Sinead Mac Manus · NESTA
View ↗
4 Feb 2020
Oral evidence session
Dr Ewa Truchanowicz · Dignio Ltd, Professor Ann Blandford · University College London, Professor Esther Rodriguez Villegas · Imperial College London, Professor Ferdinando Rodriguez y Baena · Imperial College London, Professor Praminda Caleb-Solly · West of England University, Sarah Weir OBE · Design Council, Stuart Butterfield · Canary Care
View ↗
28 Jan 2020
Oral evidence session
No witnesses recorded
View ↗
5 Nov 2019
Oral evidence session
No witnesses recorded
View ↗
29 Oct 2019
Oral evidence session
No witnesses recorded
View ↗
22 Oct 2019
Oral evidence session
No witnesses recorded
View ↗
15 Oct 2019
Oral evidence session
No witnesses recorded
View ↗

Who gave evidence

39 witnesses

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

WitnessOrganisationSessions
Ami Shpiro · Founder Innovation Warehouse 1
Catherine McClen · Founder and CEO BuddyHub 1
Charles Lowe · CEO Digital Health and Care Alliance 1
Chris Roebuck · Chief Statistician NHS Digital 1
Dame Fiona Caldicott · National Data Guardian Health and Adult Social Care Data in England 1
Dr Alison Cave · Challenge Director for the Data to Early Diagnosis and Precision Medicine Challenge UK Research and Innovation 1
Dr Anna Dixon · Chief Executive Centre for Ageing Better 1
Dr Chris Blackmore · Lecturer in mental health University of Sheffield 1
Dr Ewa Truchanowicz · Managing Director Dignio Ltd 1
Dr Fiona Marshall · Fellow Academy of Medical Sciences 1
Dr Jem Rashbass · Executive Director of Master Registries and Data NHS Digital 1
Dr Jeni Tennison · CEO Open Data Institute 1
Dr Lauren Walker · Chair of StR committee British Pharmacological Society 1
Dr Louise Wood CBE · Director of Science, Research and Evidence Department of Health and Social Care 1
Dr Paola Zaninotto · Associate Professor in Medical Statistics University College London 1
Dr Sana Suri · Alzheimer's Society Research Fellow University of Oxford 1
Dr Sheuli Porkess · Executive Director, Research, Medical and Innovation Association of the British Pharmaceutical Industry 1
George MacGinnis · Challenge Director UK Research and Innovation 1
Jim Mellon · Chairman Juvenescence 1
Luella Trickett · Director of Value and Access Association of British HealthTech Industries 1
Matthew Gould CMG MBE · CEO NHSX 1
Mr Simon Ommundsen · Head of User Experience No Isolation 1
Professor Ann Blandford · Professor of Human-Computer Interaction University College London 1
Professor Barbara Sahakian · Professor of Clinical Neuropsychology University of Cambridge 1
Professor Esther Rodriguez Villegas · Professor in Low Power Electronics Imperial College London 1
Professor Ferdinando Rodriguez y Baena · Professor of Medical Robotics Imperial College London 1
Professor Fiona Watt · Former Executive Chair Medical Research Council 1
Professor Jane Raymond · Professor of Visual Cognition University of Birmingham 1
Professor Judith Phillips OBE · Industrial Strategy Challenge Fund (ISCF) Research Director, Healthy Ageing Challenge UK Research and Innovation 1
Professor Julian Peto · Professor of Epidemiology London School of Hygiene and Tropical Medicine 1
Professor Mariana Mazzucato · Professor in Economics of Innovation and Public Value University College London (UCL) 1
Professor Praminda Caleb-Solly · Professor of Assistive Robotics and Intelligent Health Technologies West of England University 1
Professor Russell Foster · Professor of Circadian Neuroscience University of Oxford 1
Professor Sir Michael Marmot · Director of the Institute of Health Equity and Professor of Epidemiology University College London (UCL) 1
Rosamond Roughton · Director General, Adult Social Care at Department for Health and Social Care 1
Sarah Weir OBE · Chief Executive Design Council 1
Sinead Mac Manus · Senior Programme Manager, Digital Health NESTA 1
Stuart Butterfield · Managing Director Canary Care 1
Tamsin Berry · Director Office for Life Sciences 1

Correspondence

1 letter

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

Meetings & visits

11 items

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

DateTypeDetailSource
1 Dec 2020 Formal meeting (private meeting) Not recorded · Virtual meeting
17 Nov 2020 Formal meeting (private meeting) Not recorded · Virtual meeting
10 Nov 2020 Formal meeting (private meeting) Not recorded · Virtual meeting
3 Nov 2020 Formal meeting (private meeting) Not recorded · Virtual meeting
27 Oct 2020 Formal meeting (private meeting) Not recorded · Virtual meeting
20 Oct 2020 Formal meeting (private meeting) Not recorded · Virtual meeting
28 Jan 2020 Formal meeting Not recorded · Room 1, Palace of Westminster
5 Nov 2019 Formal meeting Not recorded · Room 1, Palace of Westminster
29 Oct 2019 Formal meeting Not recorded · Room 1, Palace of Westminster
22 Oct 2019 Formal meeting Not recorded · Room 1, Palace of Westminster
15 Oct 2019 Formal meeting Not recorded · Room 1, Palace of Westminster